Podcast

Fans for the Cure

Author(s):

Kristie L. Kahl

After his own journey with prostate cancer, radio and TV personality Ed Randall used his extensive connections throughout professional sports to spread awareness about prostate cancer through his nonprofit organization Fans for the Cure.

Many sports fans probably know Ed Randall best for his work as a longtime radio and TV personality and published author. But, following his own journey with cancer, Randall now utilizes his sports connections to help men across the United States get screened for prostate cancer — all through his nonprofit organization Fans for the Cure, which has helped thousands of men over an 11-year span.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Image of man with text.
Image of Dr. with text.
Image of thumbnail.
Image of Dr. Deville.
Image of Doctor.
Image of Dr. Tagawa.
Dr. Curtiland Deville Jr. discusses the importance of crafting an individualized treatment plan for patients with prostate cancer.
Use of NeuroSAFE to guide nerve sparing during robot-assisted radical prostatectomy improved patient-reported erectile function.
Dr. Chandler Park, a medical oncologist of Genitourinary Medical Oncology, at the Norton Healthcare Institute, in Louisville, Kentucky.
Dr. Guru Sonpavde emphasized the importance of better understanding how genetic mutations influence the treatment of cancer care, particularly GU cancers.
Related Content
Image of prostate
July 10th 2025

Long-Term Outcomes Support NCCN Guidelines for Prostate Cancer

Ryan Scott
Patients with nonmetastatic prostate cancer treated according to NCCN Guidelines are more likely to die of other natural causes than from their cancer.
cancer horizons logo: a white microphone on a navy blue background
March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
Stoboclo and Osenvelt, FDA-approved biosimilars of Prolia and Xgeva, are now available: © stock.adobe.com.
July 9th 2025

FDA Approves Stoboclo and Osenvelt as Biosimilars Across Some Cancers

Spencer Feldman
Stoboclo and Osenvelt, FDA-approved biosimilars of Prolia and Xgeva, are now available in the U.S. for variois cancers and cancer-related bone conditions.
cancer horizons podcast logo: a white microphone on a blue background
March 4th 2024

Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

Alex Biese Brielle Benyon
In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, and how to manage them.
Image of man.
June 26th 2025

It’s Me, A Cancer Survivor, I Refuse to Be Ignored

Brian Sluga
I was diagnosed with testicular cancer at 20. I’ve learned to embrace the pauses in life and stand proud as a survivor who won’t be ignored.
Image of Dr. Ravi, with text,
June 26th 2025

Making Prostate Cancer Easier to Understand for Those Newly Diagnosed

Ryan Scott
Dr. Ravi Munver explained that, for patients who are recently diagnosed with prostate cancer, it is important to explore treatment option with their care.